Retatrutide is an investigational peptide studied for weight loss, glucose regulation, and metabolic health
This is not a failure of the individual it reflects the mechanism
First approved for type 2 diabetes as Ozempic, the higher-dose Wegovy is intended for chronic weight management, delivering semaglutide at 15-20% of the body weight. It acts on GLP-1 receptors in the pancreas, promoting insulin secretion and reducing glucagon, which regulates blood sugar
But for some, the early momentum slows
This injectable solution marks the first FDA-approved drug for chronic weight management among adults dealing with obesity or being overweight since 2014
Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Associations overall financial information are available here